top of page
A Transformative Breakthrough
A tested, proprietary chemistry platform that cuts costs and improves product performance in a growth industry
Profile summery
Corporate Profile Summary
​
-
We design, build and sell proprietary bio-tools: reagents and components for healthcare and bioprocessing
-
Gemina advances are a 'quantum leap' in Lateral Flow Assays
The Gemina Board
Robert Greene
Chief Executive Officer
John Davies
Independent Chairman
Martin Cronin
Independent Director
Board Members
Gemina Labs News
Stay in touch with the latest news from Gemina Labs:
Corporate News
Corporate and Regulatory News is released to the press via Accesswire and can be accessed via mainstream finance news services such as Yahoo Finance.
​
Our own news page is where you'll find corporate and regulatory news, appointments, organisation & people, operations and product news.
​
You'll also find us on LinkedIn.
bottom of page